loadpatents
Patent applications and USPTO patent grants for Kattar; Solomon.The latest application filed is for "indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof".
Patent | Date |
---|---|
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof Grant 11,161,854 - Candito , et al. November 2, 2 | 2021-11-02 |
Indazolyl-spiro[2.2]pentane-carbonitrile Derivatives As Lrrk2 Inhibitors, Pharmaceutical Compositions, And Uses Thereof App 20210188863 - Candito; David Annunziato ;   et al. | 2021-06-24 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 9,938,281 - Achab , et al. April 10, 2 | 2018-04-10 |
Purine inhibitors of human phosphatidylinositol 3-kinase delta Grant 9,730,940 - Achab , et al. August 15, 2 | 2017-08-15 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20160207926 - Achab; Abdelghani Abe ;   et al. | 2016-07-21 |
Purine Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20150353552 - Achab; Abdelghani Abe ;   et al. | 2015-12-10 |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors Grant 9,096,559 - Harrington , et al. August 4, 2 | 2015-08-04 |
Aminopyrimidines as Syk inhibitors Grant 8,735,417 - Altman , et al. May 27, 2 | 2014-05-27 |
Aminopyrimidines as SYK inhibitors Grant 8,551,984 - Altman , et al. October 8, 2 | 2013-10-08 |
Therapeutic compounds Grant 8,455,477 - Katz , et al. June 4, 2 | 2013-06-04 |
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors App 20130137690 - Harrington; Paul ;   et al. | 2013-05-30 |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors Grant 8,389,553 - Harrington , et al. March 5, 2 | 2013-03-05 |
Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 Grant 8,329,722 - Siu , et al. December 11, 2 | 2012-12-11 |
Aminopyrimidines As Syk Inhibitors App 20120309735 - Altman; Michael D. ;   et al. | 2012-12-06 |
Aminopyrimidines As Syk Inhibitors App 20120277192 - Altman; Michael D. ;   et al. | 2012-11-01 |
Modified malonate derivatives Grant 8,158,825 - Grimm , et al. April 17, 2 | 2012-04-17 |
Aryl-fused spirocyclic compounds Grant 8,119,652 - Hamblett , et al. February 21, 2 | 2012-02-21 |
Aminopyrimidines As Syk Inhibitors App 20110245205 - Altman; Michael D. ;   et al. | 2011-10-06 |
Histone deacetylase inhibitors with aryl-pyrazolyl-motifs Grant 8,026,260 - Close , et al. September 27, 2 | 2011-09-27 |
Therapeutic Compounds App 20110207711 - Katz; Jason ;   et al. | 2011-08-25 |
Phosphorus derivatives as histone deacetylase inhibitors Grant 7,981,874 - Close , et al. July 19, 2 | 2011-07-19 |
4-carboxybenzylamino Derivatives As Histone Deacetylase Inhibitors App 20100324046 - Harrington; Paul ;   et al. | 2010-12-23 |
N-hydroxy-naphthalene Dicarboxamide And N-hydroxy-biphenyl-dicarboxamide Compounds As Histone Deacetylase Inhibitors App 20100216796 - Kattar; Solomon ;   et al. | 2010-08-26 |
Modified Malonate Derivatives App 20100160327 - Grimm; Jonathan ;   et al. | 2010-06-24 |
Inhibitors Of Janus Kinases And/or 3-phosphoinositide-dependent Protein Kinase-1 App 20100160309 - Siu; Tony ;   et al. | 2010-06-24 |
Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs App 20090291965 - Close; Joshua ;   et al. | 2009-11-26 |
Phosphorus Derivatives As Histone Deacetylase Inhibitors App 20090270351 - Close; Joshua ;   et al. | 2009-10-29 |
Aryl-Fused Spirocyclic Compounds App 20090239849 - Hamblett; Christopher ;   et al. | 2009-09-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.